ENSC insider filings
Ensysce Biosciences, Inc. — 32 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen ENSC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ENSC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Ensysce Biosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | GOWER BOB G — Director | Purchase (P): 508,614 @ $0.48 · Purchase (P): 400,000 @ $0.49 · Conversion (C): 254,307 (derivative) | EDGAR |
| 2023-03-06 | 4 | GOWER BOB G — Director | Purchase (P): 90,287 @ $0.49 | EDGAR |
| 2023-03-02 | 4 | GOWER BOB G — Director | Purchase (P): 109,300 @ $0.49 · Purchase (P): 270,000 @ $0.48 | EDGAR |
| 2023-02-01 | 4 | GOWER BOB G — Director | Purchase (P): 357,143 @ $1.40 · Grant/award (A): 714,286 (derivative) | EDGAR |
| 2022-06-27 | 4 | Rauch Lee M. — Director | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2022-06-27 | 4 | Rosebraugh Curtis — Director | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2022-06-27 | 4 | Benton Andrew — Director | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2022-06-27 | 4 | Levin Adam — Director | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2022-06-27 | 4 | Chang William H — Director, 10% owner | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2022-06-27 | 4 | Martin Steven Robert — Director | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2022-06-27 | 4 | GOWER BOB G — Director, 10% owner | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2022-05-27 | 4 | Kirkpatrick Lynn — Chief Executive Officer, Director | Purchase (P): 70,000 @ $0.49 · Purchase (P): 27,000 @ $0.53 · Grant/award (A): 200,000 (derivative) | EDGAR |
| 2022-02-24 | 4 | Birkett Kevin Geoffrey — Chief Commercial Officer | Grant/award (A): 50,000 (derivative) | EDGAR |
| 2022-02-24 | 4 | Humphrey David Carl — Chief Financial Officer | Grant/award (A): 80,000 (derivative) | EDGAR |
| 2022-02-24 | 4 | Kirkpatrick Lynn — Chief Executive Officer, Director | Grant/award (A): 200,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Benton Andrew — Director | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Levin Adam — Director | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Rosebraugh Curtis — Director | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Pestano Linda — Chief Development Officer | Grant/award (A): 200,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Humphrey David Carl — Chief Financial Officer | Grant/award (A): 275,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Chang William H — Director, 10% owner | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | Martin Steven Robert — Director | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2022-02-04 | 4 | GOWER BOB G — Director, 10% owner | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2021-07-02 | 4 | Benton Andrew — Director | Grant/award (A): 65,850 (derivative) | EDGAR |
| 2021-07-02 | 4 | Humphrey David Carl — Chief Financial Officer | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2021-07-02 | 4 | Wright Richard Chester — Chief Business Officer | Grant/award (A): 49,975 (derivative) · Grant/award (A): 65,850 (derivative) · Grant/award (A): 263,400 (derivative) · Grant/award (A): 19,755 (derivative) · Grant/award (A): 987,750 (derivative) | EDGAR |
| 2021-07-02 | 4 | Birkett Kevin Geoffrey — Chief Commercial Officer | Grant/award (A): 19,755 (derivative) · Grant/award (A): 329,250 (derivative) | EDGAR |
| 2021-07-02 | 4 | Chang William H — Director, 10% owner | Grant/award (A): 353,451 · Grant/award (A): 2,242,189 | EDGAR |
| 2021-07-02 | 4 | Kirkpatrick Lynn — Chief Executive Officer, Director | Grant/award (A): 284,851 · Grant/award (A): 99,950 (derivative) · Grant/award (A): 9,994 (derivative) · Grant/award (A): 263,400 (derivative) · Grant/award (A): 460,950 (derivative) · Grant/award (A): 817,560 (derivative) · +2 more | EDGAR |
| 2021-07-02 | 4 | Martin Steven Robert — Director | Grant/award (A): 65,850 (derivative) | EDGAR |
| 2021-07-02 | 4 | Schmidt William K — Chief Medical Officer | Grant/award (A): 69,142 (derivative) | EDGAR |
| 2021-07-02 | 4 | GOWER BOB G — Director, 10% owner | Grant/award (A): 7,919,026 · Grant/award (A): 6,585 (derivative) | EDGAR |
Recent 8-K events — Ensysce Biosciences, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-16 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-29 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-24 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENSC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs